Skip to main content
. 2022 Oct 29;12(11):1741. doi: 10.3390/life12111741

Table 1.

The Cho/Cr increase was significant (p = 0.0314).

Thalamus
NAA/Cr Ratio Cho/Cr Ratio GABA/Cr Ratio
Pretreatment 6 M Follow-up Pretreatment 6 M Follow-up Pretreatment 6 M Follow-up
Min. 1.43 1.46 0.81 0.99 * 0.58 0.40
Max. 1.81 2.80 1.16 1.40 0.93 0.66
Median 1.69 1.90 0.91 1.14 0.66 0.54
CI 95% 1.51–1.76 1.49–1.90 0.83–1.02 1.03–1.36 * 0.45–0.96 0.35–0.74

* p-value < 0.05.